Paper
1
CCL18 Is an IL-6 Responsive Biomarker in Systemic Sclerosis Associated Interstitial Lung Disease--Analysis from Phase 3 Trial of Tocilizumab
Authors
Published
May 1, 2020
Posted by
Save
Tip1
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.